XM does not provide services to residents of the United States of America.
A
A

Aviva

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

UK's FTSE 100 edges higher after US inflation data

UPDATE 1-UK's FTSE 100 edges higher after US inflation data For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Endeavour Mining climbs 5.9% to the top of FTSE 100 Banking group Lloyds advances 2.4% FTSE 100 up 0.3%, FTSE 250 was flat Updated at market close Dec 11 (Reuters) - Britain's FTSE 100 index nudged higher on Wednesday, led by precious metal miners, after the U.S.
A
C
E
G
L
N
U

Large UK insurers to report daily cash positions during crises under new proposals

Large UK insurers to report daily cash positions during crises under new proposals LONDON, Dec 11 (Reuters) - Large British life insurers would need to report their liquidity positions daily during market crises under new rules proposed on Wednesday by the Prudential Regulation Authority, after it identified information gaps during recent market turmoil.
A
L
P

UK's FTSE 100 has worst day in four weeks; Ashtead slumps

UPDATE 1-UK's FTSE 100 has worst day in four weeks; Ashtead slumps For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window FTSE 100 down 0.9%, FTMC down 0.4% Ashtead falls on profit warning and proposed listing move NCC Group declines after company swings to FY loss Updated at market close Dec 10 (Reuters) - Britain's FTSE 100 fell on Tuesday as mining shares slipped, while Ashtead dropped after it warned of lower than expected annual profit and
A
A
E
F
G
A
N
U

Swiss insurer Baloise nominates activist investor representative to board

UPDATE 1-Swiss insurer Baloise nominates activist investor representative to board Adds comment from Shuchna ZURICH, Dec 9 (Reuters) - Baloise BALN.S has nominated Robert Schuchna, a representative of activist shareholder Cevian Capital, to join its board of directors next year, the Swiss insurer said on Monday. Cevian, which in September became Baloise's biggest investor with a 9.4% stake, has been putting pressure on Baloise to improve its performance, saying its current strategy is not bold e
A
B
B

Swiss insurer Baloise nominates activist investor representative to board

Swiss insurer Baloise nominates activist investor representative to board ZURICH, Dec 9 (Reuters) - Baloise BALN.S has nominated Robert Schuchna, a representative of activist shareholder Cevian Capital, to join its board of directors next year, the Swiss insurer said on Monday. Cevian, which in September became Baloise's biggest investor with a 9.4% stake, has been putting pressure on Baloise to improve its performance, saying its current strategy is not bold enough.
A
B
B

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.